Abstract: |
The aim of this study was to compare the extent of in vitro T cell depletion and recovery of hematopoietic progenitor cells achieved with five methods of T cell depletion. Bone marrow samples from the same source were treated with monoclonal antibody Campath-1 (CP1) and human complement, XomaZyme-H65 (anti- T cell ricin A chain immunotoxin), or soybean agglutinin (SBA) alone or in combination with sheep erythrocytes (EAET) or a cocktail of immunomagnetic beads (B) directly coated with anti-CD2, anti-CD3, or anti-CD8 monoclonal antibodies. Residual T cells were enumerated by limiting dilution analysis, EAET rosetting, and proliferative responses to phytohemagglutinin. The results of this study demonstrated the following reductions in BM T cells as detected by limiting dilution analysis (mean % control): SBA+B (99.9%), SBA+EAET (99.8%), CP1+C' (99.4%), anti—T cell ricin A chain immunotoxin (99.0%), and SBA alone (94.2%). Neither PHA response nor enumeration of residual EAET rosettes provided discriminating differences in the degree of T cell depletion. © 1989 by The Williams and Wilkins Co. |
Keywords: |
human cell; comparative study; methodology; t lymphocyte; t-lymphocytes; animal; monoclonal antibody; lymphocyte activation; antibodies, monoclonal; leukocytes, mononuclear; hematopoietic stem cells; erythrocyte; rats; rosette formation; leukocyte count; drug combinations; bone marrow transplantation; colony-forming units assay; lymphocyte depletion; erythrocytes; depletion; complement; immunotoxins; microspheres; sheep; phytohemagglutinin; agglutinin; lectins; soybeans; human; priority journal; antitoxin; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
|